NZ565904A - Chimeric antibodies with New World primate CDR regions - Google Patents

Chimeric antibodies with New World primate CDR regions

Info

Publication number
NZ565904A
NZ565904A NZ565904A NZ56590406A NZ565904A NZ 565904 A NZ565904 A NZ 565904A NZ 565904 A NZ565904 A NZ 565904A NZ 56590406 A NZ56590406 A NZ 56590406A NZ 565904 A NZ565904 A NZ 565904A
Authority
NZ
New Zealand
Prior art keywords
antigen
binding portion
antibody
human
chimeric antibody
Prior art date
Application number
NZ565904A
Other languages
English (en)
Inventor
Philip Anthony Jennings
Anthony Gerard Doyle
Adam William Clarke
Original Assignee
Cephalon Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005904406A external-priority patent/AU2005904406A0/en
Application filed by Cephalon Australia Pty Ltd filed Critical Cephalon Australia Pty Ltd
Publication of NZ565904A publication Critical patent/NZ565904A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NZ565904A 2005-08-15 2006-08-15 Chimeric antibodies with New World primate CDR regions NZ565904A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005904406A AU2005904406A0 (en) 2005-08-15 New World Antibodies
PCT/AU2006/001166 WO2007019621A1 (en) 2005-08-15 2006-08-15 Chimeric antibodies with new world primate regions

Publications (1)

Publication Number Publication Date
NZ565904A true NZ565904A (en) 2012-02-24

Family

ID=37757238

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ565904A NZ565904A (en) 2005-08-15 2006-08-15 Chimeric antibodies with New World primate CDR regions

Country Status (13)

Country Link
EP (1) EP1945669A4 (de)
JP (1) JP2009504686A (de)
KR (1) KR20080068005A (de)
CN (2) CN101287763A (de)
AU (1) AU2006281981A1 (de)
BR (2) BRPI0614430A2 (de)
CA (1) CA2619245A1 (de)
MX (1) MX2008002161A (de)
NO (1) NO20080800L (de)
NZ (1) NZ565904A (de)
RU (1) RU2008110058A (de)
WO (1) WO2007019621A1 (de)
ZA (2) ZA200802246B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS20070027A (en) 2004-07-26 2008-11-28 Biogen Idec Ma Inc., Anti-cd154 antibodies
KR20090039666A (ko) 2006-02-01 2009-04-22 아라나 테라퓨틱스 리미티드 도메인 항체 구조체
JP5721951B2 (ja) * 2007-03-22 2015-05-20 バイオジェン アイデック マサチューセッツ インコーポレイテッド 抗体、抗体誘導体、および抗体断片を含む、ｃｄ１５４に特異的に結合する結合タンパク質ならびにその使用
CA2733742A1 (en) * 2008-08-14 2010-02-18 Cephalon Australia Pty Ltd Variant domain antibodies
RU2535034C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2517085C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2516931C2 (ru) * 2010-08-06 2014-05-20 Олег Ильич Эпштейн Способ и композиция для профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2577299C2 (ru) * 2011-07-04 2016-03-10 Олег Ильич Эпштейн Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний
RU2519862C2 (ru) * 2010-08-06 2014-06-20 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики и лечения инфекционных вирусных заболеваний
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2521392C2 (ru) * 2010-08-06 2014-06-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения вирусных заболеваний и способ лечения вирусных заболеваний
RU2505312C2 (ru) * 2010-08-06 2014-01-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения гриппа различных типов
RU2502521C2 (ru) * 2010-08-06 2013-12-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций
RU2579262C1 (ru) * 2014-10-02 2016-04-10 Мапикс Эс.Эй.Ар.Эл. Лекарственное средство для лечения инфекционных заболеваний
CL2015002152A1 (es) * 2015-07-31 2016-06-03 Pontificia Universidad Católica De Chile Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0605442B1 (de) * 1991-07-25 2003-04-16 Idec Pharmaceuticals Corporation Rekombinante antikörper zur humanen therapie
US6569431B2 (en) * 2000-10-17 2003-05-27 The Regents Of The University Of California Recombinant antibody fragments as autoantibody antagonists
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
EP2366718A3 (de) * 2002-06-28 2012-05-02 Domantis Limited Ligand
AU2004290016A1 (en) * 2003-11-07 2005-05-26 Amgen Inc. Monkey immunoglobulin sequences

Also Published As

Publication number Publication date
CA2619245A1 (en) 2007-02-22
ZA200802246B (en) 2009-09-30
ZA200802247B (en) 2009-08-26
CN101287763A (zh) 2008-10-15
BRPI0614430A2 (pt) 2011-03-29
JP2009504686A (ja) 2009-02-05
WO2007019621A1 (en) 2007-02-22
EP1945669A4 (de) 2009-07-22
CN101287762A (zh) 2008-10-15
MX2008002161A (es) 2008-04-22
RU2008110058A (ru) 2009-09-27
AU2006281981A1 (en) 2007-02-22
BRPI0614867A2 (pt) 2012-01-31
KR20080068005A (ko) 2008-07-22
NO20080800L (no) 2008-05-09
EP1945669A1 (de) 2008-07-23

Similar Documents

Publication Publication Date Title
NZ565904A (en) Chimeric antibodies with New World primate CDR regions
US20080095767A1 (en) Engineered antibodies with new world primate framework regions
US20080255343A1 (en) Chimeric antibodies
AU2007211829B2 (en) Domain antibody construct
AU2006326937B2 (en) Anti-inflammatory dAb
JP2009525031A5 (de)
MX2008002162A (en) Engineered antibodies with new world primate framework regions
WO2008092209A1 (en) Protein construct with improved properties
NZ569405A (en) Anti-inflammatory domain antibody binding to TNF-alpha
MX2008008029A (es) Dab antiinflamatorio

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed